Cifras calculadas a partir de notificaciones regulatorias oficiales — .
Propiedadiniciados 0.13% · instituciones 56.51%
En EUR · a Oct 19, 2026
Pregúntale a la máquina
Busca y compara operaciones de iniciados, sociedades y sus estadísticas en lenguaje natural. Tu pregunta se convierte en una consulta sobre los datos disponibles, no en una conversación ni en asesoramiento de inversión.
Solo datos de DBV TECHNOLOGIES. Sin búsqueda web. Se excluyen las estadísticas globales de cada iniciado.
Una búsqueda ejecutada consume un crédito, incluso sin resultados. Los errores y las preguntas no compatibles no consumen créditos.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Fuente de información de mercado · Oct 19, 2026
Cronología en el mercado · historial completo
2 compras11 ventas— precio de cierrebarra = volumen usd, escala √haz clic en un periodo para filtrar la tabla
| Iniciado | Tipo | Valor · USD | Señales | Detalle |
|---|---|---|---|---|
| Bpifrance Participations SAhistorial | Venta | $306.7K | AMF |
| Bpifrance Participations SAhistorial | Venta | $413.1K | AMF |
| Bpifrance Participations SAhistorial | Venta | $3.3M | AMF |
| Bpifrance Participations SAhistorial | Venta | $1M | AMF |
| Bpifrance Participations SAhistorial | Venta | $434K | AMF |
| Bpifrance Participations SAhistorial | Venta | $724.9K | AMF |
| Bpifrance Participations SAhistorial | Venta | $5.4M | AMF |
| Bpifrance Participations SAhistorial | Venta | $3.5M | AMF |
| Bpifrance Participations SAhistorial | Venta | $2.8M | AMF |
| Bpifrance Participations SAhistorial | Venta | $378.4K | AMF |
| Bpifrance Participations SAhistorial | EjercicioD (derivado) | $7M | AMF |
| Bpifrance Participations SAhistorial | Venta | $10.1M | AMF |
| Bpifrance Participations SAhistorial | Asignación | $4.5M | AMF |
| Daniel Tassé | Compra | $32.2K | conv 81Primera en 12 meses | AMF |
| Daniel Soland | Compra | $48.7K | conv 36Primera en 12 meses | AMF |
| Bpifrance Participations SAhistorial | Asignación | $7.9M | AMF |